Hyzaar
Product Images NDC 43353-926

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Hyzaar (NDC 43353-926). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 50/12.5mg (43353 926)

HYZAAR label showing Losartan Potassium and Hydrochlorothiazide tablets, 50 mg / 12.5 mg strength. The bottle contains 90 tablets. Manufactured by Merck Sharp & Dohme Ltd., Cramlington Northumberland, UK, and repackaged by Aphena Pharma Solutions - Tennessee, LLC, Cookeville, TN. Includes storage instructions and dispensing information.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Image Of Losartan Potassium Chemical Structure (Hyzaar 01)

Chemical structure of the active ingredients in HYZAAR, displaying the molecular configuration and potassium ion (K+).*

FDA Label Image

Image Of Hydrochlorothiazide Chemical Structure (Hyzaar 02)

Chemical structure of the active ingredient shown, displaying a chlorinated benzene ring fused with a sulfonamide group, a sulfone group, and a piperazine ring, consistent with a component of HYZAAR.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.